ZS Genetics has entered into a strategic collaboration with Hitachi High Technologies America (HTA), to develop and commercialise its new single molecule DNA sequencing platform.
It is expected that the high-resolution electron microscopy (EM) will enable the sequencing of high-quality long reads (50,000+ base-pairs) of single DNA molecules.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
ZS Genetics chief executive officer John McCarthy said: “The technical capabilities of our two companies are expected to produce a DNA sequencing platform capable of enabling unique scientific discovery, as well as offering a powerful tool to complement and broaden current short-read sequencing technologies.
"Combining ZS Genetics’ proprietary long-read technologies with HTA's leadership in high-resolution EM is expected to accelerate the introduction of this important technology into leading scientific institutions.”
Later this year, ZS Genetics intends to initiate an early-access centre in its Wakefield, Massachusetts facility for product and application development in collaboration with select customer and supply-chain partners.
HTA Nanotechnology Systems Division vice-president and general manager Phil Bryson said: “We are confident that HTA’s decades-long leadership in high-resolution EM for highly complex applications in R&D and industry can translate readily into this powerful and important new application for the life sciences industry.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataZS Genetics' DNA sequencing technology platform combines high-resolution electron microscopy with DNA sample preparation to generate long-read high-quality, single-molecule DNA sequence information.
The platform is expected to allow scientific discovery across the complex diseases, expedite the discovery and complement the existing short-read DNA sequencing technologies.
